Gilead Sciences Inc buy RudolfL
Start price
02.01.24
/
50%
€75.96
Target price
02.02.24
€80.00
Performance (%)
-6.29%
End price
22.01.24
€71.18
Summary
This prediction ended on 22.01.24 with a price of €71.18. With a performance of -6.29%, the BUY prediction for Gilead Sciences Inc by RudolfL closed slightly in the red. RudolfL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Gilead Sciences Inc | 10.442% | 10.442% |
iShares Core DAX® | 0.251% | -2.620% |
iShares Nasdaq 100 | -0.831% | 6.117% |
iShares Nikkei 225® | 0.590% | 0.921% |
iShares S&P 500 | -0.094% | 4.530% |
According to RudolfL what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Undervalued
EBIT growth >5% per year expected
Cons
Comments by RudolfL for this prediction
In the thread Gilead Sciences Inc diskutieren
Kursziel gesetzt auf 80,0
In the thread Trading Gilead Sciences Inc
Buy beendet
Stopped prediction by RudolfL for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.86
04.11.23
04.11.23
€89.00
04.12.23
04.12.23
-4.82%
05.12.23
05.12.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.89
09.01.21
09.01.21
€68.00
09.01.22
09.01.22
8.15%
30.10.21
30.10.21
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.70
22.02.20
22.02.20
€82.00
14.05.20
14.05.20
10.82%
14.05.20
14.05.20
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital